Citation Impact
Citing Papers
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels
2006 StandoutNobel
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
2020 StandoutScience
Serum Albumin
1985 Standout
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.
2007
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Long-Term Consequence of Elevated Thyroglobulin in Differentiated Thyroid Cancer
2012
Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement
2013
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases
2004
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review
2005
Diagnostic 131I whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk profile and long-term follow-up
2010
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Management and Outcome of Recurrent Well-Differentiated Thyroid Carcinoma
2004
Role of metastasectomy in the management of thyroid carcinoma: The NIH experience
2002
Thyroid Remnant 131 I Ablation for Papillary and Follicular Thyroid Carcinoma
1997
The Appendage Domain of α-Adaptin Is a High Affinity Binding Site for Dynamin
1995 StandoutNobel
Minimal-invasives follikuläres Schilddrüsenkarzinom
2010
Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer
2002
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Predicting plasma protein binding of drugs: a new approach
2002
Beta receptor isoforms are not essential for thyroid hormone-dependent acceleration of PCP-2 and myelin basic protein gene expression in the developing brains of neonatal mice
1998
131 I Therapy for Elevated Thyroglobulin Levels
1997
Type I iodothyronine deiodinase is a selenocysteine-containing enzyme
1991 StandoutNature
Regulatory T Cells
2000 StandoutNobel
EHSH1/Intersectin, a Protein That Contains EH and SH3 Domains and Binds to Dynamin and SNAP-25
1999 StandoutNobel
Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer
2005
Phantoms in the Assay Tube: Heterophile Antibody Interferences in Serum Thyroglobulin Assays
2003
Genome of the apes
2001
Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Combined with Neck Ultrasonography Has the Highest Sensitivity in Monitoring Differentiated Thyroid Carcinoma
2003
Long-Term Outcome of Patients With Differentiated Thyroid Carcinoma: Effect of Therapy
2000
Low Specificity of Blood Thyroglobulin Messenger Ribonucleic Acid Assay Prevents Its Use in the Follow-Up of Differentiated Thyroid Cancer Patients
2004
Neck recurrence from thyroid carcinoma: serum thyroglobulin and high‐dose total body scan are not reliable criteria for cure after radioiodine treatment
2005
Structure of Serum Albumin
1994 Standout
Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole‐body scan: comparative study
2003
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
1998 StandoutNature
An Overview of the Management of Papillary and Follicular Thyroid Carcinoma
1999
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
2003
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
2010
Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma
2002
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer
1997
Characterization of the Promoter of the Rat Sarcoplasmic Endoplasmic Reticulum Ca2+-ATPase 1 Gene and Analysis of Thyroid Hormone Responsiveness
1996
Extent of Thyroidectomy Is Not a Major Determinant of Survival in Low- or High-Risk Papillary Thyroid Cancer
2004
RORα Gene Expression in the Perinatal Rat Cerebellum: Ontogeny and Thyroid Hormone Regulation1
1998
Management of Differentiated Thyroid Cancer with Rising Thyroglobulin and Negative Diagnostic Radioiodine Whole Body Scan
2010
Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH
2001
Transcriptional Regulatory Patterns of the Myelin Basic Protein and Malic Enzyme Genes by the Thyroid Hormone Receptors α1 and β1
1998
Atomic structure and chemistry of human serum albumin
1992 StandoutNature
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Molecular Diagnosis of Residual and Recurrent Thyroid Cancer by Amplification of Thyroglobulin Messenger Ribonucleic Acid in Peripheral Blood1
1998
Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer
2002
Positive Predictive Value of Serum Thyroglobulin Levels, Measured during the First Year of Follow-Up after Thyroid Hormone Withdrawal, in Thyroid Cancer Patients
2003
Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies
2006
Tadpole competence and tissue‐specific temporal regulation of amphibian metamorphosis: Roles of thyroid hormone and its receptors
1996
Prospective randomized clinical trial to evaluate the optimal dose of131I for remnant ablation in patients with differentiated thyroid carcinoma
1996
Mechanism of Agonist‐Induced Down‐Regulation and Subsequent Recovery of Muscarinic Acetylcholine Receptors in a Clonal Neuroblastoma X Glioma Hybrid Cell Line
1989
Deletion of the Thyroid Hormone β1 Receptor Increases Basal and Triiodothyronine-Induced Growth Hormone Messenger Ribonucleic Acid in GH3Cells*
1997
Cytotoxic Effects of Carboplatinum and Epirubicin in the Setting of an Elevated Serum Thyrotropin for Advanced Poorly Differentiated Thyroid Cancer
2002
Differential Recognition of Target Genes by Nuclear Receptor Monomers, Dimers, and Heterodimers*
1994
SERUM THYROGLOBULIN MEASUREMENT
2001
Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years
2005
Proteomic comparison of human and great ape blood plasma reveals conserved glycosylation and differences in thyroid hormone metabolism
2001
Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine131I and Recombinant Human Thyroid Stimulating Hormone
1997
Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of radioiodine (I-131)
2012
Compassionate Use of Recombinant Human Thyrotropin to Facilitate Radioiodine Therapy: Case Report and Review of Literature
2000
Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer
2003
Update on Differentiated Thyroid Cancer Staging
2014
Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid Carcinoma
1998
Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma
1998
Post I-131 Therapy Scanning in Patients With Thyroid Carcinoma Metastases: An Unnecessary Cost or a Relevant Contribution?
2004
131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma
1996
In Situ Click Chemistry: Enzyme‐Generated Inhibitors of Carbonic Anhydrase II
2004 StandoutNobel
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer
2002
Unique response pathways are established by allosteric interactions among nuclear hormone receptors
1995
Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy
2006
Dosimetrically Determined Doses of Radioiodine for the Treatment of Metastatic Thyroid Carcinoma
2002
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
2009
Resistance of [ 18 F]-Fluorodeoxyglucose-Avid Metastatic Thyroid Cancer Lesions to Treatment with High-Dose Radioactive Iodine
2001
Recurrence After Treatment of Micropapillary Thyroid Cancer
2009
Prognosis of Differentiated Thyroid Cancer in Relation to Serum Thyrotropin and Thyroglobulin Antibody Status at Time of Diagnosis
2013
Relationship Between Tumor Burden and Serum Thyroglobulin Level in Patients with Papillary and Follicular Thyroid Carcinoma
2002
Clinical Comparison of Whole-Body Radioiodine Scan and Serum Thyroglobulin After Stimulation with Recombinant Human Thyrotropin
2002
The Effectiveness of Radioactive Iodine for Treatment of Low-Risk Thyroid Cancer: A Systematic Analysis of the Peer-Reviewed Literature from 1966 to April 2008
2010
Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus
1984
The topography of the purple membrane
1979 StandoutNatureNobel
Alpha-Adrenergic Receptor Subtypes
1980 StandoutNobel
Bacterial toxins: cellular mechanisms of action
1984
The Properties of Thyroglobulin
1966
Delineation of three different thyroid hormone-response elements in promoter of rat sarcoplasmic reticulum Ca2+ATPase gene. Demonstration that retinoid X receptor binds 5' to thyroid hormone receptor in response element 1.
1994
Diagnostic 131-Iodine Whole-Body Scan May Be Avoided in Thyroid Cancer Patients Who Have Undetectable Stimulated Serum Tg Levels After Initial Treatment
2002
Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
2003
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
1986 StandoutNobel
Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription
2000 StandoutNobel
Is Diagnostic Iodine-131 Scanning Useful after Total Thyroid Ablation for Differentiated Thyroid Cancer?
2000
Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å
1978
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
2002 Standout
Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.
2001
Lithium as a Potential Adjuvant to 131I Therapy of Metastatic, Well Differentiated Thyroid Carcinoma1
1999
Determination of the Tryptophan Content of Proteins by Ion Exchange Chromatography of Alkaline Hydrolysates
1972 StandoutNobel
Human specific loss of olfactory receptor genes
2003 StandoutNobel
Analysis of Autoimmunity through Experimental Models of Thyroiditis and Allergic Encephalomyelitis
1980
Heterogeneity of radioligand binding to alpha-adrenergic receptors. Analysis of guanine nucleotide regulation of agonist binding in relation to receptor subtypes.
1980 StandoutNobel
Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from Sencar mice.
1981
STRUCTURAL DIFFERENCES AMONG ANTIBODIES OF DIFFERENT SPECIFICITIES
1961 StandoutNobel
Serum Albumin
1970
Clathrin assembly protein AP180: primary structure, domain organization and identification of a clathrin binding site.
1993
Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
2005
Specificity and mechanism of thyroid hormone induction from an octamer response element.
1994
Mathematical theory of complex ligand-binding systems at equilibrium: Some methods for parameter fitting
1972
Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents.
1983 StandoutNobel
Zone Electrophoresis
1954
Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity.
2003
Response of thyroglobulin to radioiodine therapy in thyroglobulin-elevated negative iodine scintigraphy (TENIS) syndrome.
2011
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
The role of protein kinase C in cell surface signal transduction and tumour promotion
1984 StandoutNature
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
THYROGLOBULIN OF VARYING MOLECULAR SIZES WITH DIFFERENT DISAPPEARANCE RATES IN PLASMA FOLLOWING SUBTOTAL THYROIDECTOMY
1978
Is Above Age 45 Appropriate for Upstaging Well-Differentiated Papillary Thyroid Cancer?
2013
Nongenomic Steroid Action: Controversies, Questions, and Answers
2003
Empiric High-Dose 131-Iodine Therapy Lacks Efficacy for Treated Papillary Thyroid Cancer Patients with Detectable Serum Thyroglobulin, but Negative Cervical Sonography and 18F-Fluorodeoxyglucose Positron Emission Tomography Scan
2010
Acidification of endocytic vesicles by an ATP-dependent proton pump.
1983
Differential regulation of the α2-adrenergic receptor by Na+ and guanine nucleotides
1980 StandoutNatureNobel
The amino acid sequence of Limulus C-reactive protein. Evidence of polymorphism.
1986 StandoutNobel
The submicrosomal distribution of radioactive proteins released by puromycin from the bound ribosomes of rat liver microsomes labelled in vitro
1972
The nucleotide sequence of a human cellular thyroid hormone binding protein present in endoplasmic reticulum.
1987
Human nuclear receptor heterodimers: opportunities for detecting targets of transcriptional regulation using yeast.
1996
The amino acid sequence of the beta-subunit of ATP synthase from bovine heart mitochondria.
1983 StandoutNobel
Automatic analysis of neutral sugar components in glycoproteins and complex carbohydrates
1980
Intra- and Interspecific Variation in Primate Gene Expression Patterns
2002 StandoutScienceNobel
Polypeptide Chains of Immunoglobulins from the Smooth Dogfish ( Mustelus canis )
1966 StandoutScienceNobel
Use of Radioactive Iodine in Patients with Papillary and Follicular Thyroid Cancer: Towards A Selective Approach
1998
Characterization of thyroid hormone (T3) receptors in three osteosarcoma cell lines of distinct osteoblast phenotype: interactions among T3, vitamin D3, and retinoid signaling.
1994
Selective affinity labeling of a 27-kDa integral membrane protein in rat liver and kidney with N-bromoacetyl derivatives of L-thyroxine and 3,5,3'-triiodo-L-thyronine.
1990
Protein-Protein Interaction Domains and the Heterodimerization of Thyroid Hormone Receptor Variant α2 with Retinoid X Receptors
1998
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
2005
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Characterization of a Human Macroglobulin
1965
Lack of Impact of Radioiodine Therapy in Tg-Positive, Diagnostic Whole-Body Scan-Negative Patients with Follicular Cell-Derived Thyroid Cancer
2002
A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor.
1980 StandoutNobel
Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma.
1975 StandoutNobel
Identification by photoaffinity labeling of a membrane thyroid hormone-binding protein associated with the triiodothyronine transport system in rat erythrocytes.
1993
Dynamic Kinetic Resolution of Racemic β-Haloalcohols: Direct Access to Enantioenriched Epoxides
2008 StandoutNobel
Evidence for synthesis of scrapie prion proteins in the endocytic pathway.
1992 StandoutNobel
Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases
2009
Combination of Radioiodine (131I) and Probe-Guided Surgery for Persistent or Recurrent Thyroid Carcinoma
1998
Oligodendrocyte development and thyroid hormone
1999
Journey to the Center of the Cell: Role of the Receptosome
1981 Science
Impact of Initial Surgical Treatment on Survival of Patients with Differentiated Thyroid Cancer: Experience of an Endocrine Surgery Center in an Iodine‐deficient Region
2000
A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma
2003
Improving the Catalytic Performance of an Artificial Metalloenzyme by Computational Design
2015 StandoutNobel
Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer.
2004
The Selenoenzyme Family of Deiodinase Isozymes Controls Local Thyroid Hormone Availability
2000
Radioiodine I-131 therapy in the management of thyroid cancer.A prospective study
1977
Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts
1983 StandoutNobel
Promoter-Specific Regulation of the Brain-Derived Neurotropic Factor Gene by Thyroid Hormone in the Developing Rat Cerebellum1
1999
Guidelines for the management of thyroid cancer
2014 Standout
The Molecular Basis of Thyroid Hormone Action
1994
The N-terminal region (A/B) of rat thyroid hormone receptors alpha 1, beta 1, but not beta 2 contains a strong thyroid hormone-dependent transactivation function.
1995
Three-Dimensional Structure of Cholera Toxin Penetrating a Lipid Membrane
1988 StandoutScienceNobel
Combination of Bovine Carbonic Anhydrase with a Fluorescent Sulfonamide
1967
The Reliability of Molecular Weight Determinations by Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis
1969 Standout
Rapid acidification of endocytic vesicles containing α2-macroglobulin
1982
Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy
2012
Effect of Various Doses of Recombinant Human Thyrotropin on the Thyroid Radioactive Iodine Uptake and Serum Levels of Thyroid Hormones and Thyroglobulin in Normal Subjects
2001
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
2005
A high affinity agonist . beta-adrenergic receptor complex is an intermediate for catecholamine stimulation of adenylate cyclase in turkey and frog erythrocyte membranes.
1980 StandoutNobel
Comparison of Reduced Alkylated Derivatives of some Myeloma Globulins and Bence-Jones Proteins
1961 StandoutNatureNobel
Structure of the 116-kDa polypeptide of the clathrin-coated vesicle/synaptic vesicle proton pump
1991 StandoutNobel
The receptosome: An intermediate organelle of receptor-mediated endocytosis in cultured fibroblasts
1980
Ablation of Thyroid Residues with 30 mCi 131I: A Comparison in Thyroid Cancer Patients Prepared with Recombinant Human TSH or Thyroid Hormone Withdrawal
2002
Outcome of Differentiated Thyroid Cancer with Detectable Serum Tg and Negative Diagnostic 131I Whole Body Scan: Comparison of Patients Treated with High 131I Activities Versus Untreated Patients
2001
Molecular Basis of Thyroid Hormone-Dependent Brain Development*
1997
The Human RC3 Gene Homolog, NRGN Contains a Thyroid Hormone-Responsive Element Located in the First Intron**This work was supported by grants from Fundacion Ramon Areces and DGICYT (PM95–0019).
1999
pH and the recycling of transferrin during receptor-mediated endocytosis.
1983 StandoutNobel
RECONSTITUTION OF IMMUNOLOGIC ACTIVITY BY INTERACTION OF POLYPEPTIDE CHAINS OF ANTIBODIES
1963 StandoutNobel
Thyroid carcinoma
2003 Standout
Chemical studies on methionyl-tRNA synthetase from Escherichia coli
1970
Carbachol-activated muscarinic (M1 and M3) receptors transfected into Chinese hamster ovary cells inhibit trafficking of endosomes.
1991 StandoutNobel
Desensitization of the beta-adrenergic receptor of frog erythrocytes. Recovery and characterization of the down-regulated receptors in sequestered vesicles.
1983 StandoutNobel
Works of J Robbins being referenced
Management of thyroglobulin-positive, body scan-negative thyroid cancer patients: Evidence for the utility of I-131 therapy
1999
The Transport of Thyroxine into Mouse Neuroblastoma Cells, NB41A3: The Effect of L-System Amino Acids*
1990
Prognostic factors in the management of thyroid cancer
1995
Pharmacology of Bovine and Human Thyrotropin: An Historical Perspective
1999
Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma
1998
Purification and Partial Characterization of a Novel Thyroxine-Bindirig Protein (27K Protein) from Human Plasma*
1986
Thyroid hormone metabolism in primary cultured rat hepatocytes. Effects of glucose, glucagon, and insulin.
1981
Biosynthesis of a Novel Thyroxine-Binding Protein (27K Protein) in Human Hepatoma (Hep G2) Cells*
1986
Antithyroid effects of lithium
1970
The Use of Lithium in the Treatment of Thyrotoxicosis
1972
Separation of Thyroidal Iodoproteins and Purification of Thyroglobulin by Gel Filtration and Density Gradient Centrifugation
1964
Zone Electrophoresis in Filter Paper of Serum I131 After Radioiodide Administration.
1952
Dosimetric considerations in determining hematopoietic damage from radioactive iodine.
1953
High-affinity binding of thyroid hormones to neuroblastoma plasma membranes
1990
Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter.
1992
Characterization of human thyroxine-binding globulin. Evidence for a single polypeptide chain
1977
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.
1995
Function of Isolated Bovine Thyroid Polyribosomes
1968
Thyroxine-binding prealbumin. Conformation in urea and guanidine
1972
Thyroid Response to Human Thyrotropin in Man1
1965
Neuropsychiatric manifestations of altered thyroid state
1990
The Impact of Age and Gender on Papillary Thyroid Cancer Survival
2012
Thyroxine transport and the free hormone hypothesis.
1992
Metabolism of thyroid hormones by cultured monkey hepatocarcinoma cells. Nonphenolic ring dieodination and sulfation.
1977
27S Thyroid Iodoprotein
1965
The use of lithium in Graves' disease.
1972
The Binding of Thyroxine by Serum Albumin as Measured by Fluorescence Quenching
1966
Affinity labeling of human serum prealbumin with N-bromoacetyl-L-thyroxine.
1977
Receptor-mediated uptake of 3,3',5-triiodo-L-thyronine by cultured fibroblasts.
1980
Thyroid hormone metabolism in cultured monkey hepatocarcinoma cells. Monodeiodination activity in relation to cell growth.
1980
IODINE KINETICS DURING I-131 SCANNING IN PATIENTS WITH THYROID CANCER
1997